|
RBM9 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.475600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.259300E-03 |
| Normal-vs-Stage2 |
8.115600E-01 |
| Normal-vs-Stage3 |
6.115600E-01 |
| Normal-vs-Stage4 |
2.861000E-01 |
| Stage1-vs-Stage2 |
3.403700E-02 |
| Stage1-vs-Stage3 |
1.942280E-03 |
| Stage1-vs-Stage4 |
1.061510E-03 |
| Stage2-vs-Stage3 |
8.797600E-01 |
| Stage2-vs-Stage4 |
5.314800E-01 |
| Stage3-vs-Stage4 |
5.529000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.966180E-01 |
| Normal-vs-AfricanAmerican |
6.892800E-01 |
| Normal-vs-Asian |
9.548500E-02 |
| Caucasian-vs-AfricanAmerican |
1.967370E-01 |
| Caucasian-vs-Asian |
3.645600E-01 |
| AfricanAmerican-vs-Asian |
2.150800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.093600E-01 |
| Normal-vs-Female |
2.726000E-01 |
| Male-vs-Female |
8.457000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.909400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.378200E-02 |
| Normal-vs-Age(61-80Yrs) |
9.572400E-01 |
| Normal-vs-Age(81-100Yrs) |
6.133400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.776800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.130800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.402600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.286000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.582560E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.475200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.05599999999673E-05 |
| Normal-vs-Grade 2 |
3.264500E-03 |
| Normal-vs-Grade 3 |
5.143400E-01 |
| Normal-vs-Grade 4 |
1.638240E-01 |
| Grade 1-vs-Grade 2 |
5.104500E-02 |
| Grade 1-vs-Grade 3 |
9.77840000000452E-05 |
| Grade 1-vs-Grade 4 |
1.412690E-04 |
| Grade 2-vs-Grade 3 |
5.73229999999425E-05 |
| Grade 2-vs-Grade 4 |
3.215200E-04 |
| Grade 3-vs-Grade 4 |
3.081400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.985600E-04 |
| Normal-vs-ccB subtype |
9.100000E-01 |
| ccA subtype-vs-ccB subtype |
1.135720E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.259000E-01 |
| Normal-vs-N1 |
9.567800E-01 |
| N0-vs-N1 |
6.577000E-01 |
|
|
